公司资料
ResMed 股价、新闻与催化剂
- 股票代码:
- RMD
- 交易所:
- NYSE
- 行业:
- MedTech
- 所在地:
- United States
股票表现
220.37 USD (-1.82%)
收盘价
最后更新: 2026年8月17日
26.5B USD
市值
股价为何变动
As of Aug 17, 2026, RMD closed down 1.82% at $220.37. No new same-company headline was identified in the current news window.
公司概览
业务概览
ResMed is a medical device and digital health company focused on sleep apnea, respiratory care, and related connected-health solutions. Its business is built around device usage, recurring supplies, and software-enabled care delivery.
所在地与行业分类
Headquartered in the United States and listed on NYSE, ResMed has a global healthcare footprint. It sits in medtech and digital health rather than therapeutic biotech.
商业模式特征
The company generates revenue from PAP devices, masks, accessories, and connected-care services. Investors watch device adoption, sleep market demand, and the balance between recurring supplies and new product growth.
生物医药行业定位
ResMed is outside biotech but important in healthcare technology because of its recurring device model. It moves on procedure and chronic-care demand rather than on clinical-trial catalysts.
未来催化剂
- ResMed’s catalysts are sleep-apnea device growth, GLP-1-driven OSA awareness, and continued software / patient-care platform expansion. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。